Doug B Flora MD
Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Thoracic Cancer
Medical Oncologist | Executive Medical Director, Yung Family Cancer Center | Editor-in-Chief, AI in Precision Oncology | ACCC President-Elect | Author, Rebooting Cancer Care | CEO, TensorBlack | Keynote Speaker
7461 Pinehurst DriveAnderson, OH 45244
Overview of Dr. Flora
Dr. Doug Flora is a distinguished leader shaping the future of cancer treatment. He serves as the Executive Medical Director of Oncology Services and holds The Robert and Dell Ann Sathe Endowed Chair in Oncology at the Yung Family Cancer Center, St. Elizabeth Healthcare, driving innovation and patient-centered care.
A prominent national voice, Dr. Flora is the President-Elect of the Association of Cancer Care Centers (ACCC), where he champions excellence in cancer care delivery nationwide. Furthering his commitment to cutting-edge advancements, he is the founding Editor-in-Chief of the peer-reviewed journal, AI in Precision Oncology, guiding the integration of artificial intelligence into modern oncology practice. Dr. Flora's multifaceted expertise as a clinician, executive, and patient advocate uniquely positions him at the forefront of transforming cancer care through technology and compassionate leadership. In November, 2025, he published his first book, Rebooting Cancer Care: Can AI Make Cancer Care More Human Again?
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2005- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1999 - 2002
Ohio State University College of MedicineClass of 1999
Certifications & Licensure
KY State Medical License 2005 - 2027
OH State Medical License 1999 - 2019
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 8 citationsBendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.Ian W. Flinn, D. S. Thompson, Ralph V. Boccia, Gerald Miletello, Andrew Lipman
British Journal of Haematology. 2018-02-01 - 15 citationsA Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine CancersJohanna C. Bendell, Ahmed Zakari, Evan Z. Lang, David M. Waterhouse, Douglas Flora
Cancer Investigation. 2016-04-29 - 1 citationsProtein S deficiency in the presence of weak lupus anticoagulant resulting in right ventricular thrombosis.Douglas Flora, Somnath Ghosh, Zahida Yasin
Clinical Advances in Hematology & Oncology. 2004-03-01
Press Mentions
Medicaid Legislation Would Make Cancer Even Worse for KentuckiansMarch 25th, 2026- Opinion – Doug Flora: Patients Deserve Access to Innovative Tools in the Fight Against CancerAugust 20th, 2025
- Douglas Flora: Fighting Cancer with HeartJune 8th, 2025
Professional Memberships
- Member
External Links
- LinkedInhttp://www.linkedin.com/in/douglasflora
- Author's Pagehttps://dougflora.com/
- Substackhttps://douglasflora.substack.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
